Phase I study of intravenous BMS-2146662 FTI [farnesyl transferase inhibitor] (NSC#710086) and Herceptin (NSC#688097) weekly in patients with advanced malignancies
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2007
At a glance
- Drugs BMS 214662 (Primary) ; Trastuzumab
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 25 Oct 2007 Status changed from suspended to completed.
- 29 Sep 2005 New trial record.